Browsing by Author "Duarte, C"
Now showing 1 - 4 of 4
Results Per Page
Sort Options
- Complete Distal Rupture of the Rectus Femoris in an Elite Football Player: A Non-operative TreatmentPublication . Fernandes, A; Pinto, J; Cunha, P; Duarte, C; Estaca, A; Pereira, T; Bettencourt, M; Candelária, I; E Silva, MR
- Iliopsoas Grade 2 Myotendinous Junction Injury in an Elite Football Player: Return to Play ProcessPublication . Fernandes, A; Cunha, P; Silva, J; Duarte, C; Estaca, A; Bettencourt, M; Reis e Silva, MGroin pain is a common injury in professional footbal and widely acknowledged as a complex medical issue. Iliopsoas pathology stands as the second‐most common cause of athletic groin injury, yet iliopsoas traumatic muscle injuries are infrequent and inadequately documented in the literature. This case report outlines a grade 2 myotendinous junction injury of the iliopsoas in a football player competing in the Portuguese First League, combining an early rehabilitation protocol with ultrasound‐guided hematoma evacuation and LP‐PRP injection, enabling return to play 23 days after injury with no reported re‐injury over a period exceeding 12 months.
- Portuguese recommendations for the use of biological and targeted synthetic diseasemodifying antirheumatic drugs in patients with rheumatoid arthritis – 2020 updatePublication . Fernandes, Bruno Miguel; Guimarães, F; Almeida, DE; Neto, A; Tavares-Costa, J; Ribeiro, AR; Quintal, Alberto; Pereira, JP; Silva, L; Nóvoa, TS; Faustino, A; Vaz, C; Khmelinskii, N; Samões, B; Dourado, E; Silva, JL; Barcelos, A; Mariz, E; Guerra, M; Santos, MJ; Silvério-António, M; Teixeira, RL; Romão, VC; Santos, H; Santos-Faria, D; Azevedo, S; Rodrigues, A; Dias, JM; Lopes, C; Pinto, P; Couto, M; Miranda, LC; Bernardo, A; Cruz, M; Teixeira, F; Mourão, AF; Neto, A; Teixeira, V; Cordeiro, A; Barreira, S; Inês, LS; Capela, S; Sepriano, A; Canhão, H; Fonseca, JE; Duarte, C; Bernardes, MObjective: To update the recommendations for the treatment of rheumatoid arthritis (RA) with biological and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs), endorsed by the Portuguese Society of Rheumatology (SPR). Methods: These treatment recommendations were formulated by Portuguese rheumatologists taking into account previous recommendations, new literature evidence and consensus opinion. At a national meeting, in a virtual format, three of the ten previous recommendations were re-addressed and discussed after a more focused literature review. A first draft of the updated recommendations was elaborated by a team of SPR rheumatologists from the SPR rheumatoid arthritis study group, GEAR. The resulting document circulated among all SPR rheumatologists for discussion and input. The level of agreement with each of all the recommendations was anonymously voted online by all SPR rheumatologists. Results: These recommendations cover general aspects such as shared decision, treatment objectives, systematic assessment of disease activity and burden and its registry in Reuma.pt. Consensus was also achieved regarding specific aspects such as initiation of bDMARDs and tsDMARDs, assessment of treatment response, switching and definition of persistent remission. Conclusion: These recommendations may be used for guidance of treatment with bDMARDs and tsDMARDs in patients with RA. As more evidence becomes available and more therapies are licensed, these recommendations will be updated.
- Return to Play After the Diagnosis of Reactive Arthritis in a Professional Football PlayerPublication . Fernandes, A; Cunha, P; Pinto, J; Duarte, C; Estaca, A; Pereira, T; Bettencourt, M; e Silva, MR; Fernandes, SIn professional football, most of the injuries are traumatic; however, these athletes may suffer from rheumatologic diseases, that may present as sports-related injuries. Reactive arthritis (ReA) is classified as a sub-group of the spondyloarthritis family and is relatively rare. In this article, we highlight the successful return to play (RTP) process after the ReA diagnosis in an elite football player in the Portuguese first league. The athlete was able to RTP four months and one week after the diagnosis, had no ReA recurrence nor re-injury >8 months after RTP, and is playing at an elite level.